Nisa Investment Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Nisa Investment Advisors, LLC

$15.7 Billion
Q2 2024

A detailed history of Nisa Investment Advisors, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 22,236 shares of REGN stock, worth $23.2 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

22,236

Previous 21,448 3.67%

Holding current value

$23.2 Million

Previous $20.6 Million 13.21%

% of portfolio

0.15%

Previous 0.14%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	BUY	$883.2 - $1071.19 $695,961 - $844,097	788 Added 3.67%	22,236 $23.4 Million
Q1 2024 May 01, 2024	SELL	$902.69 - $993.35 $717,638 - $789,713	-795 Reduced 3.57%	21,448 $20.6 Million
Q4 2023 Jan 25, 2024	SELL	$775.18 - $881.7 $302,320 - $343,863	-390 Reduced 1.72%	22,243 $19.5 Million
Q3 2023 Nov 02, 2023	SELL	$692.45 - $844.37 $749,230 - $913,608	-1,082 Reduced 4.56%	22,633 $18.6 Million
Q2 2023 Aug 11, 2023	SELL	$700.03 - $830.35 $417,917 - $495,718	-597 Reduced 2.46%	23,715 $17 Million
Q1 2023 May 02, 2023	BUY	$680.49 - $826.97 $2.66 Million - $3.24 Million	3,913 Added 19.18%	24,312 $20 Million
Q4 2022 Feb 02, 2023	SELL	$705.89 - $766.39 $416,475 - $452,170	-590 Reduced 2.81%	20,399 $14.7 Million
Q3 2022 Nov 07, 2022	SELL	$573.97 - $724.32 $1.17 Million - $1.47 Million	-2,032 Reduced 8.83%	20,989 $14.5 Million
Q2 2022 Aug 03, 2022	BUY	$548.35 - $738.84 $1.37 Million - $1.84 Million	2,494 Added 12.15%	23,021 $13.6 Million
Q4 2021 Feb 03, 2022	SELL	$543.48 - $670.97 $1.26 Million - $1.55 Million	-2,315 Reduced 10.13%	20,527 $12.5 Million
Q3 2021 Oct 18, 2021	BUY	$574.03 - $680.96 $229,612 - $272,384	400 Added 1.78%	22,842 $13.8 Million
Q2 2021 Aug 06, 2021	BUY	$472.8 - $558.54 $1.06 Million - $1.26 Million	2,248 Added 11.13%	22,442 $12.5 Million
Q1 2021 Apr 26, 2021	SELL	$446.73 - $548.2 $507,038 - $622,207	-1,135 Reduced 5.32%	20,194 $9.56 Million
Q4 2020 Jan 25, 2021	SELL	$478.3 - $607.98 $880,072 - $1.12 Million	-1,840 Reduced 7.94%	21,329 $10.3 Million
Q3 2020 Oct 20, 2020	SELL	$544.75 - $658.21 $924,440 - $1.12 Million	-1,697 Reduced 6.82%	23,169 $13 Million
Q2 2020 Jul 27, 2020	SELL	$493.32 - $643.92 $2.56 Million - $3.34 Million	-5,191 Reduced 17.27%	24,866 $15.5 Million
Q1 2020 Apr 17, 2020	BUY	$336.18 - $494.43 $1.03 Million - $1.51 Million	3,060 Added 11.33%	30,057 $14.7 Million
Q4 2019 Jan 17, 2020	BUY	$274.13 - $376.51 $1.53 Million - $2.11 Million	5,597 Added 26.15%	26,997 $10.1 Million
Q3 2019 Oct 17, 2019	SELL	$273.46 - $318.39 $157,512 - $183,392	-576 Reduced 2.62%	21,400 $5.94 Million
Q2 2019 Jul 12, 2019	BUY	$299.6 - $414.82 $597,702 - $827,565	1,995 Added 9.98%	21,976 $6.88 Million
Q1 2019 Apr 17, 2019	SELL	$372.08 - $439.57 $520,912 - $615,398	-1,400 Reduced 6.55%	19,981 $8.21 Million
Q4 2018 Jan 17, 2019	SELL	$335.82 - $403.04 $87,649 - $105,193	-261 Reduced 1.21%	21,381 $7.99 Million
Q3 2018 Oct 16, 2018	BUY	$351.14 - $408.51 $1.09 Million - $1.27 Million	3,098 Added 16.71%	21,642 $8.74 Million
Q2 2018 Jul 19, 2018	SELL	$284.6 - $344.99 $2.44 Million - $2.96 Million	-8,577 Reduced 31.62%	18,544 $6.4 Million
Q1 2018 Apr 10, 2018	BUY	$315.82 - $393.78 $1.67 Million - $2.08 Million	5,286 Added 24.21%	27,121 $9.27 Million
Q4 2017 Jan 12, 2018	SELL	$358.63 - $469.95 $588,511 - $771,187	-1,641 Reduced 6.99%	21,835 $8.21 Million
Q3 2017 Oct 13, 2017	BUY	$431.38 - $504.0 $10.1 Million - $11.8 Million	23,476	23,476 $10.5 Million

Others Institutions Holding REGN

# of Institutions

1,463

Shares Held

84.5M

Call Options Held

907K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $112B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Account

Nisa Investment Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History